(1) Cooper, R. E., Williams, E., Seegobin, S., Tye, C., Kuntsi, J., & Moss, A. C. (2017). Cannabinoids in attention-deficit/hyperactivity disorder: A randomized-controlled trial. European Neuropsychopharmacology, 27(8), 795–808.
https://doi.org/10.1016/j.euroneuro.2017.05.005
(2) Blessing, E. M., Steenkamp, M. M., Manzanares, J., & Marmar, C. R. (2015). Cannabidiol as a potential treatment for anxiety disorders. Neurotherapeutics, 12(4), 825–836.
https://doi.org/10.1007/s13311-015-0387-1
(3) Babson, K. A., Sottile, J., & Morabito, D. (2017). Cannabis, cannabinoids, and sleep: A review of the literature. Current Psychiatry Reports, 19(4), 23.
https://doi.org/10.1007/s11920-017-0775-9
(4) Hernandez, M., & Levin, F. R. (2022). Attention-deficit hyperactivity disorder and therapeutic cannabis use motives. Psychiatric Clinics of North America, 45(3), 503–514.
https://doi.org/10.1016/j.psc.2022.03.008
(5) Kooij, J. S., Bejerot, S., Blackwell, A., Caci, H., Casas-Brugué, M., Carpentier, P. J., ... & Asherson, P. (2010). European consensus statement on diagnosis and treatment of adult ADHD: The European Network Adult ADHD. BMC Psychiatry, 10(1), 67.
https://doi.org/10.1186/1471-244X-10-67
Schoevers, R. A., et al. (2015). Cannabis use and adult attention deficit hyperactivity disorder. Comprehensive Psychiatry, 57, 14–21.
https://doi.org/10.1016/j.comppsych.2014.11.017
(6) Frontiers in Psychiatry. (2015). Various articles on ADHD and cannabis use. Frontiers Media S.A.
https://www.frontiersin.org/journals/psychiatry